Summary
Edwards Lifesciences Corporation (EW) announced its first-quarter 2019 financial results on April 23, 2019. This 8-K filing serves to incorporate by reference the press release containing these results, which detailed the company's performance and financial condition for the period ending March 31, 2019. Investors should review the furnished press release for specific financial metrics, operational highlights, and any forward-looking statements or guidance provided by management. The filing itself does not contain the detailed financial data but directs stakeholders to the accompanying press release for comprehensive information.
Key Highlights
- 1Edwards Lifesciences released its Q1 2019 financial results on April 23, 2019.
- 2The 8-K filing primarily serves to furnish the press release containing the financial results.
- 3Investors are directed to Exhibit 99.1, the press release dated April 23, 2019, for detailed financial information.
- 4The filing does not contain the specific financial figures but references their availability in the press release.
- 5This report covers the company's financial performance and condition for the first quarter of 2019.
Frequently Asked Questions
The main purpose of this 8-K filing is to formally report and incorporate by reference the press release issued by Edwards Lifesciences on April 23, 2019, which contains the company's financial results for the first quarter of 2019.
The detailed financial results for Q1 2019 can be found in the press release dated April 23, 2019, furnished as Exhibit 99.1 to this 8-K filing.
No, this 8-K filing does not contain the specific financial numbers itself. It directs investors to the accompanying press release (Exhibit 99.1) for that detailed information.
This report and the accompanying press release cover Edwards Lifesciences' financial results for the first quarter of 2019.